Cognitive impairment and p‐tau217 are high in a vascular patient cohort

Brain health outcomes are rarely evaluated in vascular patients. One hundred sixty-two adults with asymptomatic cardiovascular disease but without diagnoses of cognitive impairment or dementia were evaluated. Phosphorylated tau217 accurately differentiated cognitive impairment in patients with cardiovascular disease. High levels of cognitive impairment and Alzheimer's disease pathology are greatly underdiagnosed in the cardiovascular population.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-08-01
DOI
https://doi.org/10.1002/alz.70565
Citations
8
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
11.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cognitive impairment and p‐tau217 are high in a vascular patient cohort

Scott S. Berman, Joseph Sabat, Craig Weinkauf, Edward J. Bedrick et al.
8 citations
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
11.77
article

Cognitive impairment and p‐tau217 are high in a vascular patient cohort

Scott S. Berman, Joseph Sabat, Craig Weinkauf, Edward J. Bedrick, Gene E. Alexander, Luis R. León, Kevin M. Johnson, Joshua Balderman, Jeffrey L. Dage, Eric M. Reiman, John P. Pacanowski, Olivia Y. Hung, Federico Yanquez, Franchell Vazquez, Haley Wiskoski, Caronae Howell, María I. Altbach, Theodore P. Trouard, Raza Mushtaq, Francesca Vitali, Scott French, Fanny M. Elahi, Layla C. Lucas, Madeline Ally, Summan Zahra, Nicholas J. Ashton, Juan Carlos Arias, Cody Kraemer, Madison Hillis, Emma Heitkamp, Cris Escareno, Gavin Culwell, Karthik Ainapurapu
article en
8 citations

Abstract

Brain health outcomes are rarely evaluated in vascular patients. One hundred sixty-two adults with asymptomatic cardiovascular disease but without diagnoses of cognitive impairment or dementia were evaluated. Phosphorylated tau217 accurately differentiated cognitive impairment in patients with cardiovascular disease. High levels of cognitive impairment and Alzheimer's disease pathology are greatly underdiagnosed in the cardiovascular population.

Alzheimer s & DementiaVol. 21(8)
Alzheimer's Association (US), Allen Institute for Brain Science (US), Barrow Neurological Institute (US), University of Arizona (US), Arizona Science Center (US), Pima County Health Department (US), Banner - University Medical Center Tucson (US), Center for Innovation (US), Banner Sun Health Research Institute (US), Banner Alzheimer’s Institute, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US), University of Gothenburg (SE), Icahn School of Medicine at Mount Sinai (US)
Doris Duke Charitable Foundation, Arizona Alzheimer’s Consortium, Arizona Biomedical Research Commission, Health Sciences, University of Arizona, National Institute on Aging, National Heart, Lung, and Blood Institute
Openalex Percentile: Top 1%
Dementia and Cognitive Impairment Research
11.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.